Evusheld Withdrawn by FDA Jan 2023 – Ineffective Against Variants

By /
The 93% figure because BQ.1, BQ.1.1 and XBB variants including XBB.1.5 represent 93% of new cases in the US. 90% or 93%, either way Evushield is not effective.

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied